Virginia Business
Spacer
SEARCH
Spacer
NEWS CENTER
Spacer

December 2007

Home page
Current Issue
Past issues
Daily Headlines
Virginia Ideas
Editor's Blog
Spacer
TOP FEATURES
Spacer
Business Calendar
Virginia's Wealthiest
List of Leaders
Fantastic 50
Legal Elite
Super CPAs
Maritime Guide
Business Guide
Spacer
MARKET RESEARCH
Spacer
Regional Guides
Spacer
CLASSIFIEDS
Spacer
Jobs
VACommercial
Executive Services
Featured Ads
Spacer
CONTACT US
Spacer
Contact Us
Advertise With us
Planning Calendar
Subscribe
Spacer

Return to Virginia Business - December 2002

Helping the medicine go down

Kosmos Pharma faced a major challenge when it began developing its concept for medicine strips — stamp-sized strips of medicine that dissolve in the mouth negating the hassle of swallowing pills. The company had to create strips that gave patients the proper dosages of medicine, similar to those of traditional tablets or capsules.
“We had an inherently low-cost process, but we had to prove that we could, through various processes we invented, create a stable dosage form [for the medication],” says Joseph M. Fuisz, general counsel for the Great Falls-based company.

After exhaustive research, the company’s initial testing showed that the concept would work, and the Kosmos Pharma FD Tabs were created. The medicine strips, which dissolve when taken orally, are manufactured using a film that is similar to the breath-freshener strips that have recently gained mass appeal. Besides making medicine easier to swallow, the strips have other benefits: The production of the FD Tabs is low-cost when compared with traditional pill medications, Fuisz says.

“The product is processed into five foot-wide sheets of the film, which creates millions of tabs,” Fuisz says. Kosmos Pharma has patent rights to the technology and will license the product to pharmaceutical retailers, who then will set the retail price. Puerto Rico-based Mova Pharmaceutical Corp. will manufacture the tabs. Kosmos Pharma is working on the development of 15 different pharmaceutical drugs. The first products, scheduled to arrive in 2003, will be sold over the counter, and prescription drugs will be introduced sometime after.

Looking forward, Kosmos Pharma hopes to tap into the European pharmaceutical market. The company has an agreement with Wisconsin-based Allergychoices Inc. to introduce the technology to the European market as an alternative to tongue injection immunotherapy for allergies.

The Fuisz family is no stranger to the pharmaceutical industry. Fuisz and his father, Richard C. Fuisz, started Kosmos Pharma after the family’s publicly traded company, Fuisz Technologies Ltd., was sold in 1999 for $250 million. Kosmos Pharma began operations the following year, and currently has 15 employees.

— Holly M. Rodriguez

Return to Virginia Business - December 2002


Virginia Business Online | Contact Us | E-mail the editor

©2007, Media General Operations Inc., publisher of Virginia Business.
Use of this website is subject to certain terms and conditions.